SFE BES 2025 On Demand
Our 2025 meeting in Harrogate was a great success, with colleagues travelling from the UK and beyond to share in the leading-edge science and clinical practice presented. You can now catch up with the selection of on-demand talks from SfE BES, or if you were in attendance re-visit your favourite sessions from the list below, including:
- Discover What is New...? in endocrine research and clinical practice.
- Learn a new technique from our Basic and Clinical Skills talks, or the How Do I...? sessions.
Please note further sessions will be added in due course. This is based on consent from speakers.
The information in our On Demand programme was up-to-date at the time of the presentations, but does not take into account material published since then.
Clinical Endocrinology Journal Foundation Visiting Professor Lecture
Martin Fassnacht
Management of (malignant) pheochromcytoma / paraganglioma - update 2025
Society for Endocrinology Medal Lecture
speaker unavailable
Congenital Hyperinsulinism: using genetics to improve diagnosis and knowledge of disease mechanisms
Clinical Endocrinology Journal Foundation Lecture
Kristien Boelaert
Improving the management of thyroid diseases: from the bench to the bedside
Paul Foster
Empowering Students in Endocrine Science: The Establishment of the MSS Summer School
Symposium 1: Disorders of bone mineral density - mechanisms, consequences and management: Talk 1
Richard Eastell
Secondary disorders: Effects of Diabetes on the Bones
Symposium 1: Disorders of bone mineral density - mechanisms, consequences and management: Talk 2
Laurent Beck
Novel aspects of bone-kidney communication
Symposium 1: Disorders of bone mineral density - mechanisms, consequences and management: Talk 3
Secondary disorders: Effects of Glucocorticoid treatment on bone
Symposium 2: Emerging Mechanisms and Treatments in Fatty Liver: Talk 1
Hannele Yki-Jarvinen
PNPLA3 in MASLD
Symposium 3: The adipose microenvironment: the missing link between obesity and cancer?: Talk 2
Nil Grunberg
Extracellular vesicles from the peri-prostatic adipose tissue from obese, but not lean, men promotes prostate cancer aggressivity
Symposium 4 - Hot Topics in Diagnosis and Management of Pituitary Tumours: Talk 2
Yona Greenman
Cabergoline for the treatment of non-functioning pituitary adenomas
Symposium 4 - Hot Topics in Diagnosis and Management of Pituitary Tumours: Talk 3
Joanne Blair
The challenges in managing pituitary disease in late adolescent / young adult, including transition
Symposium 5 - Thyroid Cancer from Bench to Bedside: Talk 3
Sophie Leboulleux
Overview of recent thyroid cancer trials
Symposium 6 - The benign, the bad and the ugly of adrenal lumps: an update: Talk 1
John Newell-Price
Co-morbidities and mortality associated with mild autonomous cortisol excess (MACS)
Symposium 6 - The benign, the bad and the ugly of adrenal lumps: an update: Talk 2
Jérôme Bertherat
The multiple facets of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH)
Symposium 6 - The benign, the bad and the ugly of adrenal lumps: an update: Talk 3
Cristina Ronchi
Prognostication in adrenocortical carcinoma
Symposium 7 -Frontiers in non-reproductive actions of sex hormones across the lifecourse: Talk 1
Vincent Prevot
GnRH and congnition (Downs Syndrome)
Symposium 7 -Frontiers in non-reproductive actions of sex hormones across the lifecourse: Talk 3
Stephen Mangar
Evaluating the complex interplay between androgen deprivation therapy, sleep disturbance and nocturia in prostate cancer. A systemic review of prospective studies, and consideration of the emerging role of transdermal oestrogen
Meet the Expert 3 - Endocrine Cancer and Late Effects
Ruth Casey
Adrenal tumours in children, adolescents and during transition: update on management
Meet the Expert 8 - Adrenal and Cardiovascular
Irina Bancos
Tales of the unexpected in the adrenal MDT
Basic Science Workshop 1: New ways to illuminate endocrine (patho)physiology: Workshop 1
David Hodson
Single-molecule to animal
Basic Science Workshop 1: New ways to illuminate endocrine (patho)physiology: Workshop 2
Adriana Tavares
Can total-body Positron Emission Tomography (PET) imaging unravel multi-organ endocrine connectomes?
Basic Science Workshop 1: New ways to illuminate endocrine (patho)physiology: Workshop 3
Kevin Murphy
Super-resolution ultrasound
Clinical Management Workshop 1: Calcium disorders in pregnancy: Workshop 3
Stuart Ralston
Pregnancy Associated Osteoporosis
Zachary Knight
Brainstem circuits regulating appetite suppression
Alessandro Prete
How do I assess and manage HPA axis suppression from exogenous glucocorticoids?
Peter Carey
How Do I optimise Lipid therapy in patients with Atherosclerotic Cardiovascular Disease (ASCVD)?
Daniel Morganstein
How do I manage thyroid pathology after irradiation for other head and neck cancers?
Holly Mabilliard
How do I investigate and manage hypophosphataemia without hyperparathyroidism?
Legends of Endocrinology: Talk 1
Martin Hewison
Extraskeletal vitamin D: from pathological oddity to supplementation trials
Legends of Endocrinology: Talk 3
Kenneth Siddle
50 years of fascination by insulin and antibodies (standing on the shoulders of giants!)
Endocrinology in the Era of "Fake News": Talk 1
Ralitsa Madsen
A selfish guide to research integrity
Emerging Researcher Lectures & Plenary Orals: Talk 1
Hassan Massalha
Emerging Researcher Lecture (Science Lecture): A developmental cell atlas of the human thyroid gland
Emerging Researcher Lectures & Plenary Orals: Talk 2
T’ng Choong Kwok
Emerging Researcher Lecture (Clinical Lecture): Targeting human brown adipose tissue to improve cardiometabolic health
Emerging Researcher Lectures & Plenary Orals: Talk 4
Stephanie Hanna
CEJF Best Science Abstract: scRNAseq of orbital fat in thyroid eye disease reveals role of thyroid hormone signalling driving fibroblast function and identifies fibroblast-produced serum SPARC (osteonectin) as biomarker
Debate: HRT should be used for the primary prevention of disease in menopausal women
Annice Mukherjee; Richard Quinton;
Annice Mukherjee (AGAINST) - HRT should be used by default for the primary prevention of disease in menopausal women Richard Quinton (FOR) - HRT should be used by default for the primary prevention of disease in menopausal women
Nurses Session 1: Polycystic Ovary Syndrome (PCOS): Talk 1
Michael O'Reilly
Polycystic Ovary Syndrome
Nurses Session 1: Polycystic Ovary Syndrome (PCOS): Talk 2
Alison Wilcox
Supporting patients with PCOS
Nurses Session 1: Polycystic Ovary Syndrome (PCOS): Talk 3
Lucy Owusu-Darkwah
The role of the Endocrine Nurse in the management of PCOS
Nurses Session 2: Acromegaly - challenges and progress in the management of Acromegaly: Talk 1
Roz Way
The Power of Patient Advocacy and Lived Experience in Acromegaly: Insights from The Pituitary Foundation
Nurses Session 2: Acromegaly - challenges and progress in the management of Acromegaly: Talk 2
Mark Gurnell
Acromegaly 2025 - progress in diagnostic and treatment options in Acromegaly
Nurses Session 2: Acromegaly - challenges and progress in the management of Acromegaly: Talk 3
Anna Hawkins
The role of the Endocrine Specialist Nurse (ESN) in supporting Patients treatment needs in Acromegaly
Nurses Session 3: What's Innovative and New in Endocrine Nursing (WINE) session: Talk 2
Kate Davies
Overview of the Competency Framework for Paediatric Endocrine Nursing
